6US2
MTH1 in complex with compound 5
Summary for 6US2
Entry DOI | 10.2210/pdb6us2/pdb |
Descriptor | 7,8-dihydro-8-oxoguanine triphosphatase, N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide (3 entities in total) |
Functional Keywords | hydrolase, nudt1, nudix hydrolase, inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 18549.12 |
Authors | Newby, Z.E.R.,Lansdon, E.B. (deposition date: 2019-10-24, release date: 2020-04-01, Last modification date: 2023-10-11) |
Primary citation | Farand, J.,Kropf, J.E.,Blomgren, P.,Xu, J.,Schmitt, A.C.,Newby, Z.E.,Wang, T.,Murakami, E.,Barauskas, O.,Sudhamsu, J.,Feng, J.Y.,Niedziela-Majka, A.,Schultz, B.E.,Schwartz, K.,Viatchenko-Karpinski, S.,Kornyeyev, D.,Kashishian, A.,Fan, P.,Chen, X.,Lansdon, E.B.,Ports, M.O.,Currie, K.S.,Watkins, W.J.,Notte, G.T. Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation. Acs Med.Chem.Lett., 11:358-364, 2020 Cited by PubMed: 32184970DOI: 10.1021/acsmedchemlett.9b00420 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.80012657096 Å) |
Structure validation
Download full validation report